Noemi Puig, MD, PhD¹, Cristina Agullo^2*, Teresa Contreras^2*, Bruno Paiva^3,4,5*, María T Cedena^6*, Laura Rosiñol, MD, PhD^7,8,9*, Ramon Garcia-Sanz, MD, PhD^10*, Joaquin Martinez-Lopez, MD, PhD^11,12,13,14*, Albert Oriol Rocafiguera, MD^15*, María-Jesús Blanchard^16*, Rafael Ríos, MD, PhD^17*, Anna Maria Sureda Balari, MD, PhD¹⁸, Miguel Teodoro Hernández Garcia, MD, PhD^19*, Javier De La Rubia^20,21,22,23*, Felipe De Arriba, MD, PhD^24*, Luis Palomera, MD, PhD^25*, Valentín Cabañas^26*, Maria Belen Inigo Rodriguez^27*, José Juan Pérez^1*, Sergio Castro^1*, Bargay Joan^28*, Joan Bladé, MD, PhD^29,30*, Juan Jose Lahuerta Palacios^14*, Jesús San Miguel, MD, PhD^31,32,33,34* and Maria Victoria Mateos, MD, PhD^1,31,35,36

¹Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain
²Biochemistry Department, University Hospital of Salamanca, Salamanca, ESP
³Flow Cytometry Core, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
⁴Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
⁵Cancer Center Universidad de Navarra (CCUN)., Pamplona, Spain
⁶University Hospital 12 de octubre, Madrid, Spain
⁷Amyloidosis and Myeloma Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain
⁸Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁹Hematopoietic Cell Transplantation Unit,, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
¹⁰Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
¹¹Hospital 12 De Octubre, CIBERONC, Madrid, ESP
¹²Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Complutense University, CNIO, CIBERONC, Madrid, Spain
¹³Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
¹⁴Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
¹⁵Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁶Hematology, Hospital Universitario Ramon y Cajal, Madrid, Spain
¹⁷Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
¹⁸Hospital Duran i Reynals, Institut d’Investigacio Biomedica de Bellvitge (IDIBELL), Universitat de Barcelona, Barcelona, Spain, Barcelona, Spain
¹⁹Hospital Universitario de Canarias, Tenerife, Spain
²⁰Hospital Universitario y Politécnico La Fe, Valencia, Spain
²¹University Hospital La Fe, Valencia, Spain
²²Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
²³Hospital Universitario y Politécnico La Fe, Valencia, Spain
²⁴Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
²⁵Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
²⁶Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
²⁷University Hospital San Carlos, Madrid, ESP
²⁸Hospital Son Llazter, Palma de Mallorca, Spain
²⁹Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain
³⁰Hospital Clínic de Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona and GEM/PETHEMA, Barcelona, Spain
³¹Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain
³²Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain
³³Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
³⁴Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain
³⁵University Hospital of Salamanca, Salamanca, Spain
³⁶Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain

Kenneth J C Lim, MBBS^1,2, Cameron Wellard, BSc (Hons), PhD^3*, Elizabeth Moore, PhD, MPH, PgradDip (Nurs Crit Care)^4*, Slavisa Ninkovic, MBBS^5,6,7, Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP^8,9, Andrew Spencer, MBBS, MD, FRACP, FRCPA^10,11*, Peter Mollee, FRACP, MBBS, MSc, FRCPA¹², Jay Hocking, MBBS, FRACP, FRCPA, PhD^13*, Phoebe Joy Ho, MBBS, FRACP, FRCPA^14,15, Wojt Janowski, FRCPA, FRACP¹⁶, Kihyun Kim, MD, PhD¹⁷, Karen Dun, BSc^18*, Zoe K McQuilten, MBBS, PhD, FRACP, FRCPA^19*, Fiona Chen, BBiomedSc (Hons), PhD^4* and Hang Quach, MD, FRACP, FRCPA, MBBS^20,21

¹Victorian Cancer Cytogenetic Service, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia
²Haematology, St Vincent's Hospital Melbourne, Brunswick, Australia
³School of Public Health and Preventative Medicine, Monash University, Melbourne, AUS
⁴School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
⁵Haematology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia
⁶Victorian Cancer Cytogenetics Service, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia
⁷University of Melbourne, Melbourne, VIC, Australia
⁸National University Hospital, Singapore, SGP
⁹Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
¹⁰Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
¹¹Malignant Haematology and Stem Cell Transplantation Service, Alfred Health-Monash University, Melbourne, VIC, Australia
¹²Princess Alexandra Hospital, Brisbane, Australia
¹³Department of Clinical Haematology, Austin Health, Victoria, Australia, Melbourne, VIC, Australia
¹⁴Royal Prince Alfred Hospital, Sydney, AUS
¹⁵Institute of Haematology Royal Prince Alfred Hospital, University of Sydney, Sydney, AUS
¹⁶Calvary Mater Newcastle, Waratah, NSW, AUS
¹⁷Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
¹⁸Victorian Cancer Cytogenetic Service, St Vincent's Hospital Melbourne, Melbourne, AUS
¹⁹Department of Haematology, Monash Health, Melbourne, Australia
²⁰St. Vincent's Hospital Melbourne, East Melbourne, Australia
²¹Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Victoria, Australia, Melbourne, VIC, Australia

Nezar Mehanna, BA^1*, Andriy Derkach, PhD^2*, Billel Gasmi, MD^3*, Theodora Anagnostou, MD^4*, Heather Landau, MD⁴, Oscar Boutros Lahoud⁴, Michael Scordo⁵, Gunjan L. Shah⁴, Hani Hassoun, MD⁶, Kylee H Maclachlan, MBChB, PhD⁶, Malin Hultcrantz, MD, PhD⁶, Neha Korde, MD⁶, Sham Mailankody, MBBS⁶, Urvi A Shah, MD⁶, Carlyn Rose Tan, MD⁷, Saad Z Usmani, MD^5,8, Sergio A. Giralt, MD, FACP⁹, Alexander Lesokhin, MD⁷ and David Chung, MD, PhD⁵

¹Stony Brook University, Stony Brook, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Surgery Branch, National Cancer Institute, Bethesda, MD
⁴Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY

Rawan Atallah^1,2*, Yara Shatnawi, MD^2,3*, Aytaj Mammadzadeh^2,4*, Shahrukh K Hashmi, MD, MPH^5,6*, Shabeeha K Rana, MBBS, MRCP, FRCPath^7*, Muhammad Umair Mushtaq, MD^2,8, Benlazar Mohamed, MD^9*, Nihar Desai, MBBS^10*, Thiago Xavier Carneiro, MD^11*, Rakesh Popat^12*, Joseph P McGuirk, DO¹³, Shebli Atrash, MD^2,14*, Zahra Mahmoudjafari, PharmD^2,13*, Al-Ola Abdallah, MD^2,15 and Nausheen Ahmed, MD^2,8

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Jordan University of Science & Technology, Irbid, Jordan
⁴Division of Hematology/Oncology, Mayo Clinic, Rochester, MN
⁵Department of Medicine, Sheikh Shakhbout Medical City, Mayo Clinic, Abu Dhabi, United Arab Emirates
⁶Department of Medicine, Mayo Clinic, Rochester, MN
⁷American Hospital, Dubai, United Arab Emirates
⁸Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
⁹Hematology Department, University of Sidi Bel Abbès, Sidi Bel Abbès, Algeria
¹⁰Princess Margaret Cancer Centre, Toronto, ON, Canada
¹¹Hospital Ophir Loyola/State University of Para, Belém, PA, Brazil
¹²Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
¹³University of Kansas Medical Center, Westwood, KS
¹⁴Department of Hematologic Oncology & Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
¹⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS

Jessie Zhao^1,2*, Tiffany T. Khong, BSc, PhD^1,2*, Malgorzata Gorniak, BSc^3*, Abir Khaled, PhD^4*, Zac McDonald, PhD^4*, John Reynolds, BSc, MSc, PhD^1,2*, Daniel Wong^1*, Nicholas Bingham, BSc, MBBS, FRACP, FRCPA^1,2*, Anna M. Johnston, MBBS, FRACP, FRCPA⁵, Olga Motorna, BA, MBBS, FRACP, FRCPA^6*, Nicholas E. Murphy, MBBS, FRACP, FRCPA^5*, Hang Quach, MD, FRACP, FRCPA, MBBS⁷, Liqiang Yang, PhD^4* and Andrew Spencer, MBBS, MD, FRACP, FRCPA^1,2*

¹Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, Australia
²Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
³Alfred Pathology, The Alfred Hospital, Melbourne, Australia
⁴Rapid Novor, Kitchener, ON, Canada
⁵Royal Hobart Hospital, Hobart, Australia
⁶Eastern Health, Melbourne, Australia
⁷St. Vincent's Hospital Melbourne, East Melbourne, Australia

Christine Riedhammer^1*, Florian Bassermann, MD^2*, Britta Besemer, MD^3*, Moritz Bewarder, MD^4*, Franziska Brunner, MD^5*, Alexander Carpinteiro^6*, Hermann Einsele, MD, PhD^7*, Josefine Faltin, MD^8*, Jan Frenking, MD^9*, Deniz Gezer, MD^10,11*, Sarah Goldman-Mazur, MD^12*, Mathias Hanel, MD¹³, Marion Hoegner, MD^14*, K. Martin Kortüm, MD^15*, Jan Krönke, MD^16*, Miriam Kull, MD^17*, Theo Leitner, MD^18*, Christoph Mann, MD^19*, Rabea Mecklenbrauck^20*, Maximilian Merz, MD²¹, Anke Morgner^13*, Axel Nogai, MD^22*, Marc S. Raab^23*, Raphael Teipel, MD^24*, Ralph Wäsch, MD²⁵ and Leo Rasche, MD^7*

¹Department of Internal Medicine II, University Hospital Wuerzburg, Würzburg, Germany
²Department of Medicine III, School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
³University Hospital of Tuebingen, Tuebingen, Germany
⁴Department of Internal Medicine 1, Oncology, Hematology, Clinical Immunology, and Rheumatology, Saarland University Medical Center, Homburg/Saar, Germany
⁵Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany
⁶Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, DEU
⁷Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁸Department of Hematology and Stem Cell Transplantation, Helios-Klinik Berlin-Buch, Berlin, Germany
⁹Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
¹⁰Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, DEU
¹¹Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
¹²Department of Hematology, Cell therapy and Hemostaseology, University Hospital of Leipzig, Leipzig, Germany
¹³Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
¹⁴Department of Medicine III, Klinikum rechts der Isar, TUM, Muenchen, DEU
¹⁵Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
¹⁶Department of Hematology, Oncology and Cancer Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
¹⁷Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
¹⁸University Medical Center Schleswig-Holstein Campus Lϋbeck, Luebeck, DEU
¹⁹Deparment of Hematology, Oncology and Immunology, University Hospital of Gießen and Marburg, Marburg, AL, DEU
²⁰Shared senior authorship, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²¹Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
²²Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany
²³Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital, Heidelberg, Germany
²⁴Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
²⁵Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Danai Dima, MD^1,2, Aishwarya Sannareddy, MBBS^3*, Nausheen Ahmed, MD^2,4, James A Davis, PharmD^2,5*, Hira Shaikh, MBBS^2,6*, Zahra Mahmoudjafari, PharmD^2,4*, Marissa Duco, PharmD^1*, Jack Khouri, MD¹, Gurbakhash Kaur, MD, MA³, Jonathan Lochner, PharmD^6*, Faiz Anwer, MD^1,2, Aimaz Afrough, MD^2,3*, Jason Valent, MD¹, Hamza Hashmi, MD^2,5* and Al-Ola Abdallah, MD^2,4

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁴Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
⁵Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁶Division of Hematology, Oncology and Blood & Marrow Transplantation, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA

Wancheng Guo, MD^1*, David E. Mery, PhD², Eric Siegel^3*, Fumou Sun, PhD^4*, Yan Cheng, PhD^5*, Visanu Wanchai, PhD^2*, Cody Ashby, PhD^6*, Clyde Bailey, BS^7*, Daisy V. Alapat, MD⁸, Hongling Peng, MD, PhD^9*, Samer Al Hadidi, MD, MSc⁴, Sharmilan Thanendrarajan, MD^6*, Carolina Schinke, MD⁶, Maurizio Zangari, MD⁶, Frits van Rhee, MD, PhD⁶, Guido Tricot, MD^2*, John D Shaughnessy, Jr, PhD^10* and Fenghuang Zhan, MD, PhD⁶

¹Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for medical science, Little Rock, AR
²Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
³Department of Biostatistics, University of Arkansas For Medical Sciences, Little Rock, AR
⁴University of Arkansas for Medical, Little Rock, AR
⁵Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical, Little Rock, AR
⁶Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁷Myeloma Center, Winthrop P. Rockefeller Institute, University of Arkansas for Medical Sciences, Little Rock, AR
⁸Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
⁹Second Xiang-ya Hospital, Central South University, Changsha, China
¹⁰University of Arkansas For Medical Sciences, Little Rock, AR

Regina Tsay, BS^1*, Danyi Zheng, MD^1*, Sarah S. Lee, MD¹, Caitlin Gard, BS^1*, David Prince, PhD^1*, Barbara Kavanaugh, MPH^1* and Christopher Blosser, MD^1,2*

¹University of Washington, Seattle, WA
²Seattle Children’s Hospital, Seattle, WA

Asya Varshavsky-Yanovsky^1*, Yogesh Jethava, MD, FRCPath, MRCP², Don A. Stevens, MD³, Ajay K. Nooka, MD, MPH⁴, Patrick J. Stiff, MD⁵, Isabel Perez-Cruz^6*, Eric Leip^7* and Alexander Lesokhin, MD^8,9

¹Fox Chase Cancer Center, Philadelphia, PA
²Indiana Blood & Marrow Transplant, Indianapolis, IN
³Norton Cancer Institute, Louisville, KY
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁵Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
⁶Pfizer, San Diego, CA
⁷Pfizer, Cambridge, MA
⁸Weill Cornell Medicine, New York, NY
⁹Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Marc S. Raab^1*, Jonathan L. Kaufman, MD², Shambavi Richard, MD³, Sebastian Grosicki, MD, PhD^4*, Istvan Takacs^5*, Andras Strassz, MD, MBA⁶, Andreas Martin Pahl, PhD⁷, Thorsten Michael^6*, Anette Last^8*, Hajnalka Szaboki^6*, Garrit Jentsch^9*, Oliver Schönborn-Kellenberger^10* and Robert Z. Orlowski, MD, PhD¹¹

¹Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
²Winship Cancer Institute, Emory University, Atlanta, GA
³Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
⁴Department of Hematology and Cancer Prevention, Faculty of Health Sciences, Medical University of Silesia, Katowice, Poland
⁵Ist Department of Medicine, Semmelweis University, Budapest, Hungary
⁶Heidelberg Pharma AG, Ladenburg, Germany
⁷Heidelberg Pharma, Ladenburg, Bw, DEU
⁸Gregor-Mendel-Straße 22, Heidelberg Pharma AG, Ladenbuerg, Germany
⁹BAST GmbH, Heidelberg, Germany
¹⁰Cogitars GmbH, Heidelberg, Germany
¹¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Carlos BT Costa, MD^1*, Manuel Neves, MD^2*, Adriana Isabel Roque, MD, BSc^3,4*, Ana Bela Sarmento-Ribeiro, MD, PhD^5,6,7,8,9*, Rita Gerivaz, MD^10*, Ana Tomé, MD^11*, Sofia Afonso, MD^12,13*, Joana Saraiva Santos, MD^14,15*, Celina Afonso, MD^16*, Ana VRJP Afonso, MD^16*, José Freitas, MD^17*, Inês Ramos, MD^17*, Patrícia Sousa, MD^18,19*, Paula César, MD^18*, Teresa Garrido, MD^18*, Dina Rochate, MD^20*, Maria Pedro Silveira, MD^21,22*, Carolina Pestana, MsC^23*, Catarina Geraldes, MD, PhD^5,6,7,24,25*, Rui Bergantim, MD, PhD^26,27,28,29* and Cristina João, MD, MsC, PhD^23,30,31*

¹Hematology Unit, Hospital CUF Tejo, Lisbon, Portugal
²Hemato-Oncology Unit, Fundação Champalimaud, Lisbon, Portugal
³Clinical Hematolology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
⁴Institute of Physiology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
⁵Coimbra Institute for Clinical and Biomedical Research (iCBR)—Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
⁶Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
⁷Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal
⁸Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal
⁹University Clinics of Hematology and Oncology and Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, Coimbra, Portugal
¹⁰Hospital Garcia de Orta, Serviço de Hematologia, Almada, Portugal
¹¹Serviço Hematologia Clínica, Hospital Garcia de Orta, Lisbon, Portugal
¹²Serviço de Hematologia Clínica, Centro Hospitalar Universitário Cova da Beira, Covilhã, Portugal
¹³Faculdade de Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal
¹⁴Departamento de Hematologia, Centro Hospitalar de Lisboa Central, Lisbon, Portugal
¹⁵Serviço de Hematologia, [formerly at] Centro Hospitalar de Setúbal, Setúbal, Portugal
¹⁶Centro Hospitalar de Lisboa Ocidental, Serviço de Hematologia, Lisbon, Portugal
¹⁷Serviço Onco-Hematologia, Instituto Português Oncologia Porto, Porto, Portugal
¹⁸Portuguese Oncology Institute of Coimbra, Hematology Department, Coimbra, Portugal
¹⁹Hematology Department, Centro Hospitalar Universitário Cova da Beira, Covilhã, Portugal
²⁰Serviço de Hematologia, Hospital do Divino Espírito Santo de Ponta Delgada EPER, Ponta Delgada, Portugal
²¹Hematologia Clínica. Clínica de Oncologia e Radioterapia, [formerly at] Centro Clínico SAMS, Lisboa, Portugal
²²Serviço de Imuno-Hemoterapia, Hospital Prof. Doutor Fernando Fonseca, Amadora, Portugal
²³Myeloma Lymphoma Research Group, Champalimaud Foundation, Lisbon, Portugal
²⁴Clinical Hematology Department, Coimbra University Hospitals, Coimbra, Portugal
²⁵University Clinics of Hematology and Oncology and Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
²⁶Hospital S. João, Clinical Hematology, Porto, Portugal
²⁷i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal
²⁸Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, Universidade do Porto, Porto, Portugal
²⁹Clinical Hematology, Faculty of Medicine, Universidade do Porto, Porto, Portugal
³⁰Hemato-Oncology Unit, Champalimaud Foundation, Lisbon, Portugal
³¹NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal

Razan Mohty, MD¹, Whiting Junmin^2*, Aditi Saha, MBBS³, Jongphil Kim, PhD^2*, Taiga Nishihori, MD¹, Gabriel De Avila, BS^4*, Salvatore Corallo^1*, Marian Dam^1*, Jessica Marin^1*, Hien Liu, MD⁵, Sepideh Mokhtari, MD^6*, Michael D. Jain, MD, PhD¹, Fabiana Perna, MD, PhD¹, Brandon Blue, MD⁷, Ariel F. Grajales-Cruz, MD⁸, Omar Castaneda, MD⁹, Kenneth Shain, MD, PhD^8*, Rachid Baz, MD⁷, Ciara Louise L. Freeman, MD, PhD, MSc⁹, Melissa Alsina, MD^5*, Frederick L. Locke, MD¹, Doris K. Hansen, MD^5* and Aleksandr Lazaryan, MD, MPH, PhD¹

¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
²Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
³Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Moffitt Cancer Center, Tampa, FL
⁶Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, FL
⁷Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁹Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Yi Lisa Hwa, NP¹, Dragan Jevremovic, MD, PhD^2*, Shaji Kunnathu Kumar, MD³, Prashant Kapoor, MD⁴, Alissa Visram, alisvisram@toh.ca^5*, Morie A Gertz, MD^6*, David Dingli, MD⁶, Martha Lacy, MD^6*, Francis Buadi, MD³, Ronald S. Go, MD⁷, Rahma M Warsame, MD⁴, Nelson Leung, MD⁸, Wilson I. Gonsalves, MD⁹, Miriam Hobbs, CNP^1*, Amie Fonder, PA-C^1*, Michelle Rogers, CNP^1*, Joselle Cook, MBBS⁶, Moritz Binder, MD⁶, Suzanne R. Hayman, MD⁶, Taxiarchis Kourelis, MD³, S. Vincent Rajkumar, MD⁶, Robert Kyle, MD¹⁰, Angela Dispenzieri, MD⁶ and Eli Muchtar, MD⁶

¹Hematology, Mayo Clinic, Rochester, MN
²Division of Hematopathology, Mayo Clinic, Rochester, MN
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
⁶Mayo Clinic, Rochester, MN
⁷Mayo Clinic, Onalaska, WI
⁸Department of Medicine, Mayo Clinic, Rochester, Rochester, MN
⁹Division of Hematology, Mayo School of Graduate Medical Education, Rochester, MN
¹⁰Mayo Clinic, Stabile 6-28, Rochester, MN

Bingjie Fan^1* and Jishi Wang, PhD²

¹Affiliated Hospital of Guizhou Medical University, Guiyang City, China
²Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang City, China

Prashant Kapoor, MD¹, Don A. Stevens, MD^2*, Xavier Leleu, MD³, Karim Belhadj Merzoug^4*, Lionel Karlin^5*, Salomon Manier, MD, PhD⁶, Thomas Chalopin, MD^7*, Cyrille Hulin, MD^8*, Aurore Perrot, MD, PhD⁹, Jésus G Berdeja, MD¹⁰, Cristiana Costa Chase, MD¹¹, Cyrille Touzeau, MD, PhD^12*, Philippe Moreau, MD, PhD^13*, Sanjay Mohan, MD, MSCI¹⁴, Alexander Lesokhin, MD¹⁵, Carol Huff, MD¹⁶, David H. Vesole, MD, PhD¹⁷, Joshua Richter, MD¹⁸, Jeffrey V Matous, MD¹⁹, Eileen Wolff^20*, Tejas Shah^20*, Jeppe Seestern Koch-Olsen^21*, Andrew Garton, PhD^20*, Vinu Menon^22*, Sunitha Gn^23*, Mario Perro, PhD^24*, Eugene Zhukovsky^25*, Cyril Konto, MD²², Lida Pacaud, MD^22* and Mohamad Mohty, MD, PhD²⁶

¹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
²Norton Cancer Institute Brownsboro Hospital, Louisville, KY
³Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
⁴Hopital Henri Mondor, Creteil, FRA
⁵Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
⁶CHRU Lille, Lille, France
⁷Centre hospitalier universitaire de Tours, Hospital, Tours, FRA
⁸CHU Hopitaux de Bordeaux, Hôpital Haut-Lévêque, Bordeux, France
⁹Service Hematologie, CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
¹⁰Sarah Cannon Center For Blood Cancers, Nashville, TN
¹¹Duke Cancer Institute, Durham, NC
¹²Centre Hospitalier Universitaire de Nantes, Nantes, France
¹³Hematology Clinic, University Hospital Hotel-Dieu, Nantes, France
¹⁴Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
¹⁵Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁶Johns Hopkins University, Baltimore, MD
¹⁷Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
¹⁸Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁹Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO
²⁰Ichnos Sciences Inc., New York
²¹Ichnos Sciences, New York
²²Ichnos Sciences, New York, NY
²³Glenmark Pharmaceuticals Limited, Mumbai, India, Mumbai, India
²⁴Ichnos Sciences Biotherapeutics SA, Epalinges, Switzerland
²⁵Ichnos Sciences Biotherapeutics SA, Lausanne, Switzerland
²⁶Saint-Antoine Hospital, Sorbonne University, Paris, France

Yvonne Adeduni Efebera, MD, MPH¹, Vera Jean Suman, PhD^2*, Shira N. Dinner, MD³, Ashley E Rosko, MD⁴, John T Mckay, MD^5*, Peter Barth, MD⁶, Patrick Hagen, MD, MPH^7*, Saad Z Usmani, MD⁸, Paul G. Richardson, MD⁹ and Jacob P. Laubach, MD^10*

¹Division of Blood and Marrow Transplant and Cellular Therapy, OhioHealth, Columbus, OH
²Mayo Clinic, Rochester, MN
³Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁴The Ohio State University, Columbus, OH
⁵Wake Forest School of Medicine, Winston-Salem, NC
⁶Lifespan Cancer Institute, Providence, RI
⁷Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
⁸Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Dana-Farber Cancer Institute, Inc., Boston, MA
¹⁰Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, Boston, MA

Mateo Mejia Saldarriaga, MD¹, Caitlin Unkenholz^2*, Joshua A Fein, MD³, Jorge Monge, MD³, Cara Rosenbaum, MD³, Roger Pearse, MD^3*, Markus Mapara, MD⁴, Giorgio Inghirami, MD^5*, Suzanne Lentzsch, MD, PhD⁶, Ran Reshef, MD, MSc⁴, Ruben Niesvizky, MD³ and Mark Bustoros, MD³

¹Division of Hematology & Medical Oncology, Weill Cornell/New York Presbyterian, New York, NY
²Weill Cornell Medicine Medical College, New York, NY
³Division of Hematology & Medical Oncology, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
⁴Blood and Marrow Stem Cell Transplantation Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York, NY
⁵Weill Cornell Medicine, New York, NY
⁶Division of Hematology & Oncology, Columbia University Medical Center, New York, NY

Paula Tabares Gaviria, Dr.^1*, Katharina Schmiedgen^2*, Jayabhuvaneshwari Dhanraj^1*, Hüsniye Dagdeviren^3*, Amy Wilnit^3*, Maria Ulbrich^3*, Bruno Paiva^4*, K. Martin Kortüm, MD^5*, Leo Rasche, MD^5,6*, Hermann Einsele, MD, PhD^5*, Andreas Beilhack, MD^7* and Johannes M Waldschmidt, MD⁸

¹Interdisciplinary Center for Clinical Research Laboratory, Würzburg University Hospital, Würzburg, Germany., 97078 Würzburg, Germany
²Interdisciplinary Center for Clinical Research Laboratory, Würzburg University Hospital, Würzburg, Germany., Würzburg, DEU
³Interdisciplinary Center for Clinical Research Laboratory, Würzburg University Hospital, Würzburg, Germany., Würzburg, Germany
⁴Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada., Pamplona, Spain
⁵Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
⁶University Hospital of Würzburg, Würzburg, Germany
⁷Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
⁸Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Baden Wurttemberg, Germany

Kylee H Maclachlan, MBChB, PhD¹, Bachisio Ziccheddu^2*, Carlyn Tan, MD³, Tala Shekarkhand, MS^1*, Colin Rueda^1*, Edith Serrano^4*, Benjamin Diamond, MD², Hani Hassoun, MD¹, Sham Mailankody, MBBS¹, Urvi A Shah, MD¹, Malin Hultcrantz, MD, PhD¹, Sergio A. Giralt, MD, FACP⁵, David Chung, MD, PhD⁵, Heather Landau, MD⁵, Oscar Boutros Lahoud⁵, Michael Scordo⁵, Gunjan L. Shah⁶, Yanming Zhang, M.D.⁷, Robert Cimera^8*, Maria E. Arcila, M.D.^9*, Ola Landgren, MD², Alexander Lesokhin, MD¹, Neha Korde, MD¹, Francesco Maura, MD¹⁰ and Saad Z Usmani, MD¹¹

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
³Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY
⁹Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL
¹¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Tadeusz Kubicki^1,2*, Ben A Derman, MD³, Krzysztof Jamroziak^4*, Pawel Robak^5*, Jaroslaw Czyz^6*, Agata Tyczynska^7*, Agnieszka Druzd-Sitek^8*, Krzysztof Giannopoulos^9*, Tomasz Wrobel, MD, PhD^10*, Adam Nowicki^2*, Tomasz Szczepaniak^2*, Anna Lojko-Dankowska^2*, Magdalena Matuszak^2*, Lidia Gil², Bartosz Michal Pula^4*, Lukasz Szukalski^6*, Agnieszka Konska^4*, Jan M. Zaucha^7*, Jan Walewski⁸, Damian Mikulski^5*, Olga Czabak^11*, Tadeusz Robak^5*, Dorota Kruk-Kwapisz^12*, Andrzej J Jakubowiak, MD, PhD¹ and Dominik Dytfeld^2*

¹University of Chicago, Chicago, IL
²Poznan University of Medical Sciences, Poznan, Poland
³University of Chicago, CHICAGO, IL
⁴Institute of Hematology and Blood Transfusion, Warsaw, Poland
⁵Medical University of Lodz, Lodz, Poland
⁶Nicolaus Copernicus University in Torun Ludwik Rydygier, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
⁷Medical University of Gdansk, Gdansk, Poland
⁸Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
⁹Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
¹⁰Wroclaw Medical University, Wroclaw, Poland
¹¹Medical University of Lublin, Lublin, Poland
¹²Clinscience, Warsaw, Poland

Mohamed Elmeliegy, PhD^1*, Hoi Kei Lon^2*, Diane Wang, PhD^3*, Wei An Ma^4*, Lindsay King^5*, Andrea Viqueira, MD^6* and Akos Czibere^5*

¹Pfizer, San Diego, CA
²Pfizer, Inc., San Diego
³Pfizer Inc., San Diego, CA
⁴Pfizer, Inc., San Diego, CA
⁵Pfizer, Inc., Cambridge, MA
⁶Pfizer SLU, 28108, Madrid, ESP

Humberto Martinez-Cordero, MD, MSc^1,2,3*, Maria Cynthia Fuentes Lacouture, MD^3*, Seisha Alana Von Glasenapp, MD^4*, Camila Peña, MD⁵ and Eloisa Riva, MD, MEd^6*

¹Instituto Nacional de Cancerología, Bogota, Colombia
²Instituto Nacional de Cancerología, Bogotá, Colombia
³Hospital Militar Central, Bogotá, Colombia
⁴Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
⁵Hospital Del Salvador, Santiago, CHL
⁶Hospital De Clínicas, Montevideo, Montevideo, URY

Sireesha Asoori, MBBS, MPH^1*, Rakesh Popat^2*, Joaquín Martínez-Lopez^3*, Efstathios Kastritis, MD^4*, Larissa Brunaldi^5*, Radhika Bansal, MBBS^5*, Andre De Menezes Silva Corraes, MD^5*, Kwee Yong², Catriona Mactier, MD^2*, Magdalena Corona^3*, Adolfo Jesús Sáez Marín, MD^3*, Despina Fotiou^6*, Meletios A. Dimopoulos⁶, Saurabh Chhabra, MD, MS⁷, Sikander Ailawadhi^8*, Ricardo Parrondo, MD⁸, Thomas Martin, MD¹, Brian GM Durie, MD⁹ and Yi Lin, MD, PhD⁵

¹University of California, San Francisco, CA
²University College London, London, United Kingdom
³University of Complutense, Hospital 12 de Octubre, Madrid, Spain
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵Mayo Clinic Cancer Center, Rochester, MN
⁶Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
⁷Mayo Clinic, Phoenix, AZ
⁸Mayo Clinic, Jacksonville, FL
⁹International Myeloma Foundation, Studio City, CA

Noureen Asghar, MD^1*, Syed Arsalan Naqvi, MBBS^2*, Kanwal Asghar, MBBS^3*, Joseph Thirumalareddy^1*, Mohsin Mirza^1*, Muhammad Husnain, M.D.⁴, Rajshekhar Chakraborty, MD⁵, Bradley Devrieze^6*, Abraham Mathews, MD⁷, Irbaz Bin Riaz^8* and Mohammed Aljama, MBBS, FRCPC^9*

¹Creighton University, Omaha, NE
²Mayo Clinic, Phoenix, AZ
³Dow Medical College, Karachi, Pakistan
⁴University of Arizona, Tucson, AZ
⁵Columbia University Irving Medical Center, Thornwood, NY
⁶Creighton University, Omaha
⁷Hematology & Oncology Consultants, Omaha, NE
⁸Dana-Farber Cancer Institute, Boston, MA
⁹Juravinski Cancer Centre, Hamilton, ON, CAN

Youngeun Lee^1*, Nuri Lee, M.D., Ph.D.^2*, Sung-Soo Yoon, MD, PhD^3,4, Jong Hyun Yoon, M.D., Ph.D.^5,6* and Dong Soon Lee, M.D., Ph.D.⁶

¹Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
²Department of Laboratory Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea, Republic of (South)
³Seoul National University Hospital, Seoul, South Korea
⁴Department of Tumor Biology, Cancer Research Institute, Seoul, Korea, Republic of (South)
⁵Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, Republic of (South)
⁶Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea, Republic of (South)

Oliver Van Oekelen, MD, PhD¹, Morgan Van Kesteren^2*, Adolfo Aleman, MPA¹, Ariel Kogan Zajdman^1*, Lucia Y Chen, MD^3*, Tarek H. Mouhieddine, MD³, Bhaskar Upadhyaya, PhD^3*, Kseniya Serebryakova^1*, Katerina Kappes, BSc^1*, Sarita Agte, MD^1*, Annika Oostenink^2*, Hayley Jackson^2*, Charles Gleason^2*, Komal Srivastava^2*, Santiago Thibaud, MD^1*, Larysa Sanchez, MD^1*, Cesar Rodriguez, MD^3*, Joshua Richter, MD¹, Hearn Jay Cho, MD⁴, Adriana C Rossi, MD, MSc³, Shambavi Richard, MD³, Carlos Cordon-Cardo, MD^5*, Ania Wajnberg, MD^6*, Florian Krammer, PhD^2*, Sundar Jagannath^7*, Viviana Simon, MD, PhD^2* and Samir Parekh, MD³

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
⁴Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Tisch Cancer Institute, New York, NY
⁵Department of Pathology, Icahn School of Medicine At Mount Sinai, NEW YORK, NY
⁶Department of Medicine, General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
⁷Mount Sinai Medical Center, New York, NY

Ariel F. Grajales-Cruz, MD¹, Omar Castaneda, MD², Doris K. Hansen, MD^3*, Mariola A Vazquez-Martinez, MD⁴, Brandon Blue, MD⁵, Sushmita Khadka, MD⁴, Hien Liu, MD³, Jose L. Ochoa-Bayona, MD^6*, Ciara Louise L. Freeman, MD, PhD, MSc², Frederick L. Locke, MD⁶, Taiga Nishihori, MD⁶, Kenneth Shain, MD, PhD^1*, Rachid Baz, MD⁵ and Melissa Alsina, MD^7*

¹H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Moffitt Cancer Center, Tampa, FL
⁴H Lee Moffitt Cancer Center & Research Institute, Tampa
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁷H. Lee Moffitt Cancer Ctr. Hematologic Malignancies Program, Tampa, FL

Camila Peña, MD¹, Virginia Bove^2,3*, Eloisa Riva^4*, Patricio Duarte^5*, Cesar Augusto Samanez-Figari, MD^6*, Cristian M Seehaus, MD^7*, Luz Tarin-Arzaga, MD^8*, Seisha Alana Von Glasenapp, MD^9*, Rodrigo Meneces Bustillo, MD^10*, Jule F Vasquez, MD¹¹, Marcos Hernandez^12*, Claudia Shanley, MD^13*, Moisés Manuel Gallardo-Pérez, MD, MSc^14,15*, Guillermo José Ruiz-Arguelles, FRCP^14,16, Romina Mariano, MD^17*, Virginia Gilli^18*, David Israel Garrido, MD^19*, Patricia Graffigna, MD^20*, Natalia Paola Schutz, MD²¹ and Dorotea Fantl, MD²²

¹Hospital Del Salvador, Santiago, Chile
²Hospital Central de las FF.AA., Mintevideo, Uruguay
³Centro de Asistencia de la Agrupación Médica de Pando, Montevideo, Uruguay
⁴Clinical Hospital Dr. Manuel Quintela De Clinicas, Montevideo, Uruguay
⁵CEMIC, Buenos Aires, Argentina
⁶AUNA, Lima, Peru
⁷Hospital Italiano de Buenos Aires, Buenos Aires, ARG
⁸HU UANL, Monterrey, YU, MEX
⁹HCIPS, Asuncion, AL, PRY
¹⁰Sanatorio Allende, Córdoba, Argentina
¹¹Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
¹²Metropolitano del norte universidad de Carabobo, Caracas, VEN
¹³Hospital Británico Buenos Aires, Bueno Aires, Argentina
¹⁴Universidad Popular Autónoma del Estado de Puebla, Puebla, PU, Mexico
¹⁵Investigación Clínica, Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, MEX
¹⁶Centro De Hematologia Medicina Interna, Puebla, Pue, Mexico
¹⁷HOSIPTAL SAN MARTIN, Buenos Aires, ARG
¹⁸Hospital San Martín, Parana, Argentina
¹⁹Hospital de Clinicas, Montevideo, URY
²⁰Hospital del Salvador, Santiago, CHL
²¹Hematology, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
²²Hospital Italiano de Buenos Aires, Buenos Aires, BA, ARG

Konstantinos Soureas^1,2*, Christos Minopoulos^1*, Maria-Alexandra Papadimitriou^1*, Panagiotis Malandrakis, MD^3*, Panagiotis Adamopoulos^4*, Ioannis Ntanasis-Stathopoulos^5*, Aristea-Maria Papanota^6*, Maria Gavriatopoulou, MD, PhD^3*, Diamantis C Sideris^1*, Efstathios Kastritis, MD^3*, Meletios A. Dimopoulos⁷, Andreas Scorilas^1*, Evangelos Terpos, MD, PhD⁸ and Margaritis Avgeris^1,2*

¹Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Faculty of Biology, Athens, Greece
²Laboratory of Clinical Biochemistry – Molecular Diagnostics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Biochemistry and Molecular Biology, National and Kapodistrian University of Athens, Faculty of Biolgy, Athens, Greece
⁵National and Kapodistrian University of Athens, School of Medicine, Athens, GRC
⁶Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Alexandra General Hospital, ATHENS, Greece
⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
⁸Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece

Michael Slade, MD, MSCI¹, Abir Khaled, PhD^2*, Mark Fiala, PhD^1*, Zac McDonald, PhD^2*, Mariya Liyasova, PhD^3*, Julie Fortier, PhD^1*, Mark Zaydman, MD, PhD⁴, Sarah Kelley, BS^1*, Zachary David Crees, MD^1,5, Mark A. Schroeder, MD¹, Keith Stockerl-Goldstein, MD¹, Liqiang Yang, PhD^2* and Ravi Vij, MD, MBA¹

¹Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Rapid Novor, Kitchener, ON, Canada
³Rapid Novor Inc., Kitchener, ON, Canada
⁴Division of Pathology, Washington University School of Medicine, St Louis, MO
⁵Division of Oncology, Washington University School of Medicine, Frontenac, MO

Laure Vincent, MD^1*, Olivier Decaux, MD, PhD^2*, Aurore Perrot, MD, PhD³, Bruno Royer, MD^4*, Thomas Chalopin, MD^5*, Arthur Bobin^6*, Margaret Macro, MD^7*, Denis Caillot, MD^8*, Lionel Karlin^9*, Caroline Jacquet, MD^10*, Cécile Sonntag, MD^11*, Mohamad Mohty, MD, PhD¹², Laurent Frenzel, MD, PhD^13*, Arnaud Jaccard^14,15*, Laurence Sanhes^16*, Driss Chaoui^17*, Nathalie Texier^18*, Chanaz Louni^19*, Zakaria Maarouf^20*, Herve Avet Loiseau, MD, PhD²¹, Cyrille Hulin, MD^22,23* and Karim Belhadj Merzoug, MD^24*

¹Department of Clinical Hematology, Montpellier University Hospital Center, Montpellier, France
²Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes, France
³CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
⁴Saint Louis Hospital, Paris, France
⁵Centre hospitalier universitaire de Tours, Hospital, Tours, FRA
⁶CHU Poitiers, Poitiers, France
⁷Hopital Cote De Nacre, Caen, France
⁸University Hospital INSERM UMR1231 and SAPHIIR-UMR 1231, University of Burgundy & France Comte, Dijon, France
⁹Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
¹⁰CHU de Nancy, Vandoeuvre Les Nancy, FRA
¹¹University Hospital, Hôpital Hautepierre, Strasbourg, France
¹²Department of Haematology, Saint Antoine Hospital, Paris, France
¹³Department of Haematology, Institut Necker, Paris, FRA
¹⁴Referral Center for AL Amyloidosis, Limoges, France
¹⁵Hematologie clinique, CHU de Limoges, HoPital Dupuytren, Limoges Cedex 1, FRA
¹⁶Centre Hospitalier Perpignan, Perpignan, FRA
¹⁷hôpital Victor Dupouy 33134232447, Argenteuil, FRA
¹⁸Kappa Santé, PARIS, FRA
¹⁹IFM, Paris, France
²⁰IFM, Paris, IDF, France
²¹Iuct-Oncopole Toulouse, Toulouse, FRA
²²Centre Hospitalier Universitaire Bordeaux, Bordeaux, France
²³Centre Hospitalier Universitaire de Bordeaux, Pessac Cedex, FRA
²⁴Unité Hémopathies Lymphoïdes, Centre Hospitalier Universitaire Henri Mondor, Créteil, France

Kamal Alzahrani, MD^1,2, Oren Pasvolsky, MD^1,3,4*, Zhongya Wang, MS^5*, Denái R. Milton, MS^5*, Mark R. Tanner, PhD^1*, Qaiser Bashir, MD¹, Samer A. Srour, MD¹, Neeraj Y. Saini, MD¹, Paul Lin, MD, PhD¹, Jeremy Ramdial, MD¹, Yago Nieto, MD, PhD¹, Hans Lee, MD⁶, Krina K. Patel, MD, MSc⁶, Elisabet E. Manasanch, MD⁶, Partow Kebriaei, MD¹, Sheeba K. Thomas, MD⁶, Donna M. Weber, MD⁶, Robert Z. Orlowski, MD, PhD⁷, Elizabeth J. Shpall, MD¹, Richard E. Champlin, MD¹ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Adult Hematology and Bone Marrow Transplant, King Fahad Medical City, Riyadh, Saudi Arabia
³Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
⁴Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Vania T.M Hungria, MD¹, Katja Weisel, MD², Atanas Radinoff³, Sosana Delimpasi^4*, Gabor Mikala^5*, Tamas Masszi^6*, Jian Li^7*, Marcelo Capra⁸, Angelo Maiolino^9*, Vasiliki Pappa^10*, Dominik Chraniuk^11*, Iurii Osipov^12*, Xavier Leleu, MD¹³, Michael Low^14*, Morio Matsumoto^15*, Mary Li^16*, Neal Sule^16*, Margaret Polinkovsky^17*, Randy Davis^16*, Shelley Bright^16*, Astrid McKeown^18*, Joanna Opalinska^16* and Meletios A. Dimopoulos¹⁹

¹Department of Hematology, Clinica São Germano, São Paulo, Brazil
²University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
³Department of Clinical Hematology, University Hospital "St Ivan Rilski" EAD, Sofia, Bulgaria
⁴General Hospital Evangelismos, Athens, Greece
⁵South Pest Central Hospital, National Institute for Haematology and Infectious Diseases, Budapest, Hungary
⁶Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary
⁷Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
⁸Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
⁹Instituto Americas de Ensino,, Pesquisa e Inovacao, Rio de Janeiro, Brazil
¹⁰Second Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital "Attikon", Athens, Greece
¹¹Department of Hematology, Wojewodzki Szpital Zespolony, Torun, Poland
¹²V.A. Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation
¹³Service D'Hématologie Et Thérapie Cellulaire, Poitiers, France
¹⁴Monash Haematology, Monash University, Clayton University, Victoria, Australia
¹⁵Department of Hematology, Shibukawa Medical Center, Shibukawa, Japan
¹⁶GSK, Upper Providence, PA
¹⁷GSK, Research Triangle Park, NC
¹⁸GSK, Stevenage, United Kingdom
¹⁹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece

Katherine Radwanski, MS^*, Junhua Yu, PhD^*, Kody Pierce, PharmD^*, Chetasi Talati, MD, Steve Stricker, MS, PharmD^*, Shiyin Jiao, PhD^* and Orlando Bueno, MD, PhD

AbbVie Inc., North Chicago, IL

James E. Hoffman^1*, Naresh Bumma, MD², Joshua Richter, MD³, Madhav V. Dhodapkar, MD, PhD⁴, Hans Lee, MD⁵, Attaya Suvannasankha^6*, Jeffrey A. Zonder, MD⁷, Joseph J. Maly^8*, Mansi R. Shah^9*, Rachid Baz, MD¹⁰, Swathi Namburi¹¹, Ka Lung Wu, MD, PhD¹², Matthew Pianko¹³, Jing Christine Ye¹³, Suzanne Lentzsch, MD, PhD¹⁴, Rebecca Silbermann¹⁵, Chang-Ki Min^16*, Marie-Christiane Vekemans^17*, Markus Munder^18*, Ja Min Byun^19*, Joaquín Martínez Lopez^20*, Michelle DeVeaux^21*, Cristina Ivanescu^22*, Karen Rodriguez Lorenc²¹, Glenn S. Kroog^21*, Yariv Houvras^21*, Timothy J. Inocencio^21*, Lei Chi^21*, James Harnett^21*, Qiufei Ma^21* and Sundar Jagannath³

¹University of Miami Health System, Miami, FL
²The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
³Icahn School of Medicine at Mount Sinai, New York, NY
⁴Emory University School of Medicine, Atlanta, GA
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Indiana University Simon Cancer Center and Roudebush VAMC, Indianapolis, IN
⁷Karmanos Cancer Institute, Detroit, MI
⁸Norton Cancer Institute, Louisville, KY
⁹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹⁰H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
¹¹Swedish Cancer Institute, Seattle, WA
¹²Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp, Belgium
¹³Universty of Michigan, Rogel Cancer Center, Ann Arbor, MI
¹⁴Division of Hematology & Oncology, Columbia University Medical Center, New York, NY
¹⁵Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹⁶Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁷Department of Internal Medicine, Université Catholique de Louvain (UCLouvain), Brussels, Belgium
¹⁸Third Department of Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
¹⁹Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²⁰Hospital Universitario 12 de octubre, Universidad Complutense, CNIO, Madrid, Spain
²¹Regeneron Pharmaceuticals, Inc., Tarrytown, NY
²²IQVIA, Patient Centered Solutions, Amsterdam, The Netherlands

Luciano Di Stefano, PhD^1*, Zarouki Mouktadi, MSc^2*, Victor Vimard^1*, Sarah Moreau^1*, Sandrine Mace^3*, Zandra K. Klippel, MD⁴, Vincent Bonifay, PhD^1*, Caroline Rougé Dubroc^1* and Pierre Sonigo^1*

¹SEBIA, Lisses, France
²SEBIA, Lisses, AL, France
³SANOFI R&D, Chilly-Mazarin, France
⁴SANOFI R&D, Vitry-sur-Seine, France

Razan Mansour^1,2*, James A Davis, PharmD^1,3*, Megan Minchak^4*, Rawan Atallah^1,5*, Md Saiful Islam Saif^6*, Emerson Logan^7*, Carine Tabak^7*, Aliya Rashid, DO, MPH², Danai Dima, MD^1,8, Nausheen Ahmed, MD^1,9, Al-Ola Abdallah, MD^1,9 and Hamza Hashmi, MD^1,10*

¹US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
²Internal Medicine, University of Kansas Medical Center, Kansas City, KS
³Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁴Department of Hematology-Oncology, Medical College of South Carolina, Charleston, SC
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Redwood City, CA
⁶Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, KS
⁷University of Kansas School of Medicine, Kansas City, KS
⁸Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹⁰Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC

Sherif Louis, PhD^1*, Sabine Mai^2* and Hans Knecht, MD³

¹Telo Genomics Corp., Toronto, ON, Canada
²University of Manitoba, Winnipeg, MB, CAN
³Hôpital Général Juif - Sir Mortimer B. Davis, Montréal, QC, CAN

Karun Neupane, MD, MBBS¹, Gliceida Galarza Fortuna, MD^2*, Riyasha Dahal, MBBS^3*, Timothy M Schmidt, MD⁴, Rafael Fonseca, MD⁵, Doug Sborov⁶, Meera Mohan, MD⁷, Hira Mian, MD⁸, Rajshekhar Chakraborty, MD⁹ and Ghulam Rehman Mohyuddin, MD¹⁰

¹Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY
²Department of Internal Medicine, University of Utah, Salt Lake City, UT
³Universal College of Medical Sciences, Bhairahawa, Nepal
⁴University of Wisconsin School of Medicine and Public Health, Madison, WI
⁵Mayo Clinic, Phoenix, AZ
⁶University of Utah School of Medicine, Salt Lake City, UT
⁷BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁸Juravinski Cancer Center, Hamilton, ON, Canada
⁹Columbia University Medical Center, New York, NY
¹⁰Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Arleigh McCurdy, MD, BSc¹, Engin Gul, BSc, MBA^2*, Donna Reece, MD^2,3, Christopher P. Venner, MD⁴, Darrell White, MD⁵, Jiandong Su, MSc^2*, Michael P. Chu, MD⁶, Victor H. Jimenez-Zepeda, MD⁷, Kevin Song, MD, FRCPC⁸, Hira Mian, MD⁹, Michael Sebag, MD, PhD¹⁰, Debra Bergstrom, MD, BSc, FRCPC¹¹, Julie Stakiw, MD, FRCPC¹², Anthony Reiman, MD¹³, Rami Kotb, MD¹⁴, Muhammad Aslam, FRCPath, MBBS^15*, Rayan Kaedbey, MD¹⁶, Martha L Louzada, MD, MSc¹⁷ and Richard LeBlanc, MD, FRCPC^18,19

¹The Ottawa Hospital, Ottawa, ON, Canada
²Canadian Myeloma Research Group, Vaughan, ON, Canada
³Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴BC Cancer – Vancouver Centre, University of British Columbia, Vancouver, BC, Canada
⁵Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
⁶Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁷Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁸BC Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada
⁹Juravinski Cancer Center, Hamilton, ON, Canada
¹⁰McGill University, Montréal, QC, Canada
¹¹Memorial University of Newfoundland, St John’s, NF, Canada
¹²University of Saskatchewan, Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹³Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada
¹⁴Cancer Care Manitoba, Winnipeg, Canada
¹⁵Allan Blair Cancer Centre, Regina, SK, CAN
¹⁶Jewish General Hospital, Montréal, QC, Canada
¹⁷London Health Sciences Centre, London, ON, Canada
¹⁸Maisonneuve-Rosemont Hospital, Montreal, QC, CAN
¹⁹Université de Montréal, Montréal, QC, Canada

Ian Lund, PA-C^1*, Farhan Azad, DO¹, Kristopher Attwood, PhD, MS^2*, Anthony George, MS^1* and Jens Hillengass, MD, PhD³

¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Department of Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Roswell Park, Buffalo, NY

Molly Reed^1*, David Allan Cairns, PhD^2*, Charlotte Pawlyn, MBBChir, PhD^3,4, Faith E. Davies, MD⁵, Rachel Sigsworth^6*, Annamaria Brioli, MD, PhD^7*, Matthew W. Jenner^8*, Martin F. Kaiser, MD, FRCP, FRCPath^4,9, Catherine Olivier^10*, Roger Owen, MD, MRCP, FRCPath^11*, Kevin Boyd^4*, Gordon Cook, PhD^12*, Gareth J. Morgan, M.D., Ph.D.^13*, Graham Jackson^14*, Mark Drayson^15* and John R Jones^1,16,17*

¹Brighton and Sussex Medical School, Brighton, United Kingdom
²Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, ENG, United Kingdom
³Institute of Cancer Research, Sutton, United Kingdom
⁴The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁵NYU Langone Health, New York, NY
⁶Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁷Klinik für Innere Medizin C, Universitätsmedizin Greifswald, Greisfwald, Germany
⁸University Hospital Southampton, Southampton, United Kingdom
⁹The Institute of Cancer Research, London, ENG, United Kingdom
¹⁰Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
¹¹Leeds Teaching Hospitals NHS Trust, Haematological Malignancies Diagnostics Service, Leeds, United Kingdom
¹²Leeds Myeloma Research Group and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
¹³Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
¹⁴University of Newcastle, Department of Haematology, Newcastle, United Kingdom
¹⁵University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹⁶Kings College Hospital, London, United Kingdom
¹⁷East Sussex NHS Trust, Eastbourne, United Kingdom

Jonathan Scolnick, PhD^1*, Stacy Xu, PhD^2*, Cinnie Soekojo, MRCP (UK), FRCPath^3*, Fangfang Song^4*, Melissa Ooi, PhD, FRCPath, MBBChir, MRCP^5,6*, Chandramouli Nagarajan, MD, MBBS, FRCP, FRCPath^7*, Wee-Joo Chng, MBBS, PhD, FRCPath, FRCP^8,9,10,11,12 and Sanjay De Mel, BSc, FRCPath, MRCP^13*

¹Singleron Biothechnologies Pte Ltd, Singapore, Singapore
²Singleron Biotechnologies Pte LtD, Singapore, Singapore
³National University Cancer Institute, Singapore, National University Health Syst, Singapore, MD, SGP
⁴Haematology Oncology, National University Cancer Institute Singapore, Singapore, Singapore
⁵National University Cancer Institute, Singapore, Singapore
⁶National University Health System, Singapore, Singapore
⁷Singapore General Hospital, SingHealth Duke NUS Blood Cancer Center and Singapore General Hospital, Singapore, Singapore
⁸National University Hospital National University Cancer Institute, Singapore, Singapore
⁹Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
¹⁰National University Hospital, Singapore, SGP
¹¹Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
¹²Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
¹³Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore

Orla McCourt, PhD^1*, David Allan Cairns, PhD^2*, Sally Moore^3*, Christopher Parrish, MBBChir, MRCP, FRCPath, MA, PhD^4,5, Charlotte Pawlyn, MBBChir, PhD^6,7, Frances Seymour^4,8*, Ethan R Senior, MMath^5*, Kara-Louise Royle^5*, Jennifer Bird, MBBS, MRCP^9*, Stella J. Bowcock^10*, Alan Chant^11*, Mark Drayson^12*, Hayley Gardner^13*, Matthew W. Jenner^14*, John R Jones^15*, Martin F. Kaiser, MD, FRCP, FRCPath^16,17, Bhuvan Kishore^18*, Roger Owen, MD, MRCP, FRCPath^19*, Neil Rabin^1*, Ruth M de Tute, MSc, PhD, FRCPath^20*, Bryony Dawkins^21*, David Meads, PhD^21*, Sharon Gillson, BSc^22*, Sharon Jackson^23*, Catherine Olivier^5*, Graham Jackson^24* and Gordon Cook, PhD^5,8*

¹Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, ENG, United Kingdom
³Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
⁴Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
⁵Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, United Kingdom
⁶Institute of Cancer Research, Sutton, United Kingdom
⁷The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁸Leeds Myeloma Research Group and NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
⁹Bristol Haem/Onc Center, Bristol, GBR
¹⁰Princess Royal University Hospital, King’s College Hospital NHS Foundation Trust,, London, United Kingdom
¹¹Patient and Public Contributor, NA, United Kingdom
¹²University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, United Kingdom
¹³Heart of England NHS trust, Birmingham, GBR
¹⁴University Hospital Southampton, Southampton, United Kingdom
¹⁵Brighton and Sussex Medical School, Brighton, United Kingdom
¹⁶The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
¹⁷The Institute of Cancer Research, London, ENG, United Kingdom
¹⁸Heartofengland NHS FT, Birmingham, GBR
¹⁹Leeds Teaching Hospitals NHS Trust, Haematological Malignancies Diagnostics Service, Leeds, United Kingdom
²⁰HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
²¹University of Leeds, Academic Unit of Health Economics, Leeds, United Kingdom
²²Leeds Institute of Clinical Trials Research, Cancer Research UK Clinical Trials Unit, Leeds, GBR
²³Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
²⁴University of Newcastle, Department of Haematology, Newcastle, United Kingdom

Ryan Danis^1*, David Yashar^2*, Sean Bujarski^1,2*, Scott Jew^1,2*, Regina Swift^1* and James R Berenson, MD^1,2,3

¹Berenson Cancer Center, West Hollywood, CA
²Institute for Myeloma and Bone Cancer Research, West Hollywood, CA
³Oncotherapeutics, West Hollywood, CA

Kylee H Maclachlan, MBChB, PhD¹, Carlyn Rose Tan, MD^2*, Tala Shekarkhand, MS^1*, Colin Rueda^1*, Edith Serrano^3*, David Nemirovsky, MS^4*, Andriy Derkach, PhD^4*, Andrew McPherson, PhD^5*, Benjamin Diamond, M.D.^6*, Bachisio Ziccheddu^6*, Eileen Boyle, MBChB, PhD⁷, Hani Hassoun, MD¹, Sham Mailankody, MBBS¹, Urvi A Shah, MD¹, Malin Hultcrantz, MD, PhD¹, Sergio A. Giralt, MD, FACP⁸, David Chung, MD, PhD⁸, Heather Landau, MD⁸, Oscar Boutros Lahoud⁸, Michael Scordo⁸, Gunjan L. Shah⁹, Yanming Zhang, M.D.¹⁰, Robert Cimera^11*, Maria E. Arcila, M.D.^12*, Ahmet Dogan, MD, PhD¹³, Alexander Lesokhin, MD¹, Gareth J. Morgan, M.D., Ph.D.^14*, Ola Landgren, MD⁶, Francesco Maura, MD¹⁵, Neha Korde, MD¹ and Saad Z Usmani, MD²

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Computational Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
⁷Department of Hematology, UCL Cancer Institute, London, United Kingdom
⁸Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY
¹²Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Perlmutter Cancer Center, Multiple Myeloma Research Program, NYU Grossman School of Medicine, NYU Langone Health, New York, NY
¹⁵Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL

Jiangbo Zhang^1*, Hua Xue^2*, Rong Fu^3*, Jing Wang^1*, Songying Zhao^1*, Huimei Guo^1*, Jia Liu^1*, Jianmei Xu^1* and Yao Liu, PhD, MD⁴

¹Affiliated Hospital of Hebei University, Baoding, China
²Affiliated Hospital of Hebei University, Baoding City, Hebei Province, China
³Tianjin Medical University General Hospital, Tianjin, China
⁴Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China

Sven Schimanski, MD^1*, Hannah Hornburger, MD^2*, Sofie-Katrin Kadel, MD^3*, Anna Marie Ruckdeschel, MD^4*, Florian Eisele^5*, Daniela Schneider^1*, Anke Heidemeier, MD^6*, Andreas Buck, MD^7*, Rudolf Werner, MD^7*, Johannes M Waldschmidt, MD⁸, Paula Tabares^9*, Andreas Beilhack, MD^10*, Johannes Duell, MD^11*, Hermann Einsele, MD, PhD^12*, K. Martin Kortüm, MD^10*, Max S. Topp, MD^11* and Leo Rasche, MD^12*

¹Department of Internal Medicine 2, University Hospital Wuerzburg, Wuerzburg, Germany
²Department of Internal Medicine 2, University Hospital Wuerzburg, Wuerzburg, DEU
³Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany
⁴Department of Medicine II, Hematology and Oncology, University Hospital of Wuerzburg, Wuerzburg, Germany
⁵Department of Internal Medicine II, University Hospital Würzburg, WüRzburg, Germany
⁶Department of Diagnostic Radiology, University Hospital Wuerzburg, Wuerzburg, Germany
⁷Department of Nuclear Medicine, University Hospital Wuerzburg, Wuerzburg, Germany
⁸Department of Internal Medicine II, University of Wuerzburg Medical Center, Wuerzburg, Germany
⁹University Hospital of Wuerzburg, Wuerzburg, DEU
¹⁰Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
¹¹Department of Internal Medicine II, Hematology and Oncology, University Hospital Wuerzburg, Wuerzburg, Germany
¹²Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Annita Ioanna Gkioka, MD^1*, Alexandros Gkiokas, MD^1*, Alexandros Alexandropoulos, MD^1*, Mavra Papadatou, MD^1*, Aspasia Koudouna, MD^1*, Bartzi Vasiliki, MD^1*, Thomai-Marina Tryfou, MSc^1*, Nikolitsa Kafasi, MD^2* and Marie-Christine Kyrtsonis, MD¹

¹First Department of Propaedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
²Laikon General Hospital, Department of Immunology & Histocompatibility, Athens, Greece

Robert M. Rifkin, MD¹, Jeff P. Sharman, MD², Jessica Fowler, PhD^3*, Thomas S. Lin, MD, PhD³, Brian Thomson, PharmD^4* and Jesus G. Berdeja, MD⁵

¹US Oncology Research, Rocky Mountain Cancer Centers, Denver, CO
²Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
³Johnson & Johnson, Horsham, PA
⁴Janssen Pharmaceuticals, Horsham, PA
⁵Sarah Cannon Research Institute, Nashville, TN

Mehdi M. Moezi, MD¹, Mohamad Kanaan, MD^2*, Patrick M. Travis^3*, Tara Graff^4*, Cheng Zheng^5*, Jessa Dunivan^5*, Tiffany Wood, BS^6*, Sophia Essiet^6*, Jessica Faucheaux^6*, Brian Decker^7*, Jennifer Wren^5*, Leena Chhun^5*, Jayne Piboonvaranggoon^5*, Mark Walker, Phd^8*, Trudy Buckingham^9*, Joseph Guidi^10*, Shannon Altimari^11* and C. Anthony Blau, MD^5*

¹Cancer Specialists of North Florida, Fleming Island Cancer Center, Fleming Island, FL
²Northwest Medical Specialties, Puyallup, WA
³Highlands Oncology Group, Rogers, AR
⁴Mission Cancer and Blood, Des Moines, IA
⁵All4Cure, Seattle, WA
⁶Exigent Research, Tacoma, WA
⁷Electronic Medical Office Logistics (EMOL Health), Royal Oak, MI
⁸Walker Research Consulting, Germantown, TN
⁹GSK, Durham, NC
¹⁰GSK, Collegeville, PA
¹¹GSK, Baar, Switzerland

Agoston Gyula Szabo¹, Silvia Sánchez-Ramón^2*, Csaba Siffel^3*, Colin Anderson-Smits^3*, Barbara McCoy^4* and Marta Kamieniak^3*

¹Department of Haematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
²Department of Clinical Immunology, Institute of Laboratory Medicine, Hospital Clínico San Carlos, Complutense University of Madrid, Madris, Spain
³Takeda Development Center Americas, Inc., Cambridge, MA
⁴Baxalta Innovations GmbH, a Takeda company, Vienna, Austria